Alcocer F, Whitley D, Salazar-Gonzales J, Jordan W, Sellers M, Eckhoff D, Suzuki K, Macrae C & Bland K, 2002, ‘Quercetin inhibits human vascular smooth muscle cell proliferation and migration’, Surgery, vol 131, Pages 198-204.

Ames BN, 2001, ‘DNA damage from micronutrient deficiencies is likely to be a major cause of cancer’, Mutation Research, vol 475 (1-2), Pages 7-20. Review.

Ames BN, Liu J, Atamna H & Hagen TM, 2003, ‘Delaying the mitochondrial decay of ageing in the brain’, Clinical Neuroscience Research, vol 2, Issue 5-6, Pages 331-338.

Ames BN, 2005,’Increasing longevity by tuning up metabolism’, EMBO Reports, 6(S1): S20–S24.

Ames BN, Atamna H & Killilea DW, 2005, ‘Mineral and vitamin deficiencies can accelerate the mitochondrial decay of aging’, Molecular Aspects of Medicine, vol 26, Pages 363-378.

Ames BN, 2006, ‘Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage’, Proceedings of the National Academy of Sciences of the United States of America, vol 103, no 47, Pages 17589- 17594.

Ames BN, McCann JC, Stampfer MJ & Willett WC, 2007, ‘Letter to the Editor: Evidence-based decision making on micronutrients and chronic disease: long-term randomized controlled trails are not enough’, American Journal of Clinical Nutrition, vol 86, Page 522-3.

Australian Government Department of Health and Ageing, NHMRC – Nutrient Reference Values for Australia and New Zealand.

Barch DH, Rundhaugen LM, Stoner GD, Pillay NS & Rosche WA, 1996, ‘Structure-function relationships of the dietary anticarcinogen ellagic acid’, Carcinogenesis, vol 17, no 2, Pages 265-269.

Barringer TA, Kirk J, Santaniellio A, Foley KL & Michielutte R, 2003, ‘Effect of a multivitamin and mineral supplement on infection and quality of life: A randomised, double-blind placebo-controlled trial’, Annals of Internal Medicine, vol 138, issue 5, Pages 365-371.

Baur, JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA, 2006, ‘Resveratrol improves health and survival of mice on a high-calorie diet’, Nature, vol 444(7117), Pages 337-342. No-Nonsense Nutrition Resource

Beltramo E, Berrone E, Buttiglieri S & Porta M, 2004,  ‘Thiamine and benfotiamine prevent increased apoptosis in endothelial cells and pericytes cultured in high glucose’ Diabetes/Metabolism Research and Reviews, vol 20, no 4, Pages 330-336.

Benford D, Theoretical basis for Harm. NIH State-of-the –Science Conference on Multivtiamin/Mineral Supplements and Chronic Disease Prevention 2006, May: 73-75.

Best, Ben, The World of Ben Best

Birkmayer W, Birkmayer JGD, Vrecko K, Paletta B, Reschenhofer E and Ott E, 1990, ‘Nicotinamide Adenine Dinucleotide (NADH) as Medication for Parkinson’s Disease. Experience with 415 Patients’, New Trends in Clinical Neuro Pharmacology, vol 4, no 1, Pages 7-24.

Birkmayer JGD & Birkmayer W, 1991, ‘The coenzyme nicotinamide adenine dinucleotide (NADH) as biological antidepressive agent: experience with 205 patients’, New Trends in Clinical Neuro Pharmacology, vol 5, Pages 19–25.

Birkmayer JG, 1996, ‘Coenzyme nicotinamide adenine dinucleotide: new therapeutic approach for improving dementia of the Alzheimer type’, Annals of Clinical & Laboratory Science, vol 26, no 1, Pages 1–9.

Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M & Green MS, 2000, ‘Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial’, Lancet, vol 356, (9237) Pages 1213-1218.

Boldyrev, AA, Stvolinsky, SL, Tyulina, OV & Koshelev, VB, 1997, ‘Biochemical and physiological evidence that carnosine is an endogenous neuroprotector against free radicals’, Cellular and Molecular Neurobiology,  Vol 17, no 2, Pages 259-271.

Brookes Paul S, Digerness Stanley B, Parks Dale A. & Darley-Usmar Victor, 2002, ‘Mitochondrial function in response to cardiac ischemia-reperfusion after oral treatment with quercetin’, Free Radical Biology & Medicine, vol 32, no 11, Pages 1220-8.

Boucher BJ, 1998, ‘Inadequate vitamin D status: does it contribute to the disorders comprising syndrome ‘X’?’, The British Journal of Nutrition, vol 79, no 4, Pages 315-327.

Brumas V, Hacht B, Filella M & Berthon G, 1992, ‘ Can N-acetyl-L-cysteine affect zinc metabolism when used as a paracetamol antidote?’, Agents and Actions, vol 36, (3-4):Pages 278- 288.